Loading stock data…
PBH
$55.09-1.23 (-2.18%)
Market ClosedLast close May 1
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Prestige Consumer Healthcare Inc. in the Healthcare sector is trading at $55.09. The stock is currently near its 52-week low of $51.24, remaining 13.4% below its 200-day moving average. Technical signals show neutral RSI of 43 and bullish MACD crossover, explaining why PBH maintains its current current market pressure. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 43) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$55.09
Potential Upside
34.7%
Whystock Fair Value$74.19
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.75B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
15.09
Beta
Defensive asset. Lower volatility than the S&P 500.
0.47
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
11.64%
Volume
Today's trading volume
580,057
Recent News
Has Prestige Consumer Healthcare (PBH) Fallen Too Far After Its 32% One-Year Share Price Drop
If you are wondering whether Prestige Consumer Healthcare's share price still reflects its underlying worth, it helps to start with how the market has been treating the stock recently. The share price last closed at US$55.13, with returns of a 5.8% decline over 7 days, a 17.9% decline over 30 days, a 9.9% decline year to date, a 32.3% decline over 1 year, a 13.1% decline over 3 years and a 24.4% gain over 5 years. Recent price weakness has come as investors reassess consumer health names...
Prestige Consumer Healthcare (PBH) Is Down 10.3% After Rising FTC Scrutiny and Bearish Signals - What's Changed
In early April 2026, Prestige Consumer Healthcare’s shares came under pressure as heightened regulatory concerns around healthcare consolidation and anticompetitive behavior unsettled investors and coincided with bearish technical trading signals. The combination of sector-wide regulatory anxiety and short-term technical weakness has introduced a new layer of uncertainty for Prestige, even as analysts’ broader view on the business remains more constructive. Against this backdrop of...
A Look At Premium Brands Holdings (TSX:PBH) Valuation After Recent Share Price Weakness
Premium Brands Holdings (TSX:PBH) has been drawing attention after a period of weak share performance, with the stock down about 16% over the past month and 19% in the past 3 months. See our latest analysis for Premium Brands Holdings. Zooming out, Premium Brands Holdings now trades at CA$82.71, with recent weakness reflected in a 30 day share price return of a 16.39% decline. The 1 year total shareholder return of 12.35% shows a very different longer term picture. If you are weighing what...
Prestige Consumer Healthcare’s (PBH) Free Cash Flow to Enterprise Value Stood at 6.5%
Heartland Advisors, an investment management company, released its “Heartland Opportunistic Value Equity Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Large- and mega-cap stocks posted another quarter of outperformance in Q4, despite a brief broad-based performance across market caps. The Russell 2000® Index of small stocks returned 2.19% in the […]
Sector Update: Health Care Stocks Retreat Late Afternoon
Health care stocks declined late Friday afternoon, with the NYSE Health Care Index and the State Str